hBD-1 vs Ipamorelin
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Ipamorelin (Growth Hormone Secretagogue) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | Ipamorelin |
|---|---|---|
| Category | Dental & Oral | Performance |
| Full Name | Human beta-defensin 1 | Growth Hormone Secretagogue |
| Molecular Weight | 4490 Da | 711.85 Da |
| Half-Life | minutes to hours | ~2 hours |
| Amino Acids | 36 | 5 |
| Typical Dose | 1-10 µg/mL in experimental studies | 200-300 mcg |
| Route | Topical/Intraoral | SC |
| Purity | ≥98% | — |
| Studies Count | 85 | 156 |
| Research Status | Pre-clinical | Clinical Trials |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Ipamorelin Benefits
- ✓Stimulates natural GH release
- ✓Minimal cortisol/prolactin increase
- ✓Improved body composition
- ✓Enhanced recovery and sleep quality
- ✓Anti-aging effects
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Ipamorelin Dosing
Standard: 200-300 mcg SC 2-3 times daily|Pre-bed: 200 mcg SC 30 min before sleep|Combined: 100-200 mcg with CJC-1295 2-3x daily
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Ipamorelin Side Effects
- ⚠Common (Mild): Temporary tingling, water retention, increased appetite
- ⚠Rare: Headache, lightheadedness
- ⚠Very Well Tolerated overall
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Ipamorelin
Ipamorelin has moderate clinical evidence. Phase II trials demonstrate selective GH release. Generally regarded as one of the safest GH secretagogues with minimal side effect profile.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.